Who is sponsoring NCT05365074?

NCT05365074 is sponsored by Hôpital de la Croix-Rousse.

What drugs are being tested in NCT05365074?

Interventions in NCT05365074: Chloroprocaine Injection.

What condition does NCT05365074 study?

NCT05365074 studies Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia.

Is NCT05365074 still recruiting?

NCT05365074 is currently completed. Last updated 9 May 2022.

Last reviewed 2022-05-09 · How we verify

NCT05365074

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intrathecal Chloroprocaine for Lower Limb Arthroplasty

Completed Last updated 9 May 2022

What this trial tests

trial testing Chloroprocaine Injection in Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia in 65 participants. Completed in 2 March 2022.

Timeline

1 January 2020

Primary endpoint
31 December 2021

2 March 2022

Quick facts

Lead sponsor	Hôpital de la Croix-Rousse
Status	Completed
Study type	OBSERVATIONAL
Enrollment	65
Start date	1 January 2020
Primary completion	31 December 2021
Estimated completion	2 March 2022
Sites	1 location across France

Drugs / interventions tested

Chloroprocaine Injection — full drug profile →

Conditions studied

Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia — all drugs for Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia →

Sponsor

Hôpital de la Croix-Rousse

Who can join

Eligibility, any sex, with Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the perioperative course in adult patients undergoing total or partial knee arthroplasty, or total hip arthroplasty under chloroprocaine spinal anesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty-Consecutive Case Series Study.
Alhefeiti K, Patrascu AM, Lustig S, Aubrun F, et al · · 2022 · cited 4× · PMID 36233638 · DOI 10.3390/jcm11195771

Verify or expand the search:

Other trials of Chloroprocaine Injection

Trials testing the same drug.

NCT07444827 — Targeted Nerve Injection to the Knee (Nerve to Vastus Medialis): Comparing Two Adductor Canal Block Approaches · Phase 4 · not yet recruiting
NCT07239999 — Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpatient Primary Total · Phase 4 · not yet recruiting

Other Hôpital de la Croix-Rousse trials

Trials by the same sponsor.

NCT06865313 — Functional Evaluation After Maxillectomy and Scapular Free Flap Reconstruction · completed
NCT03635944 — Nutritional Care and Head Growth in Preterm Infants · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05365074 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hôpital de la Croix-Rousse
Last refreshed: 9 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05365074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing